文献速递乳房整形与再造创面修复

术前使用5-羟色胺能抗抑郁药与自体乳房再造并发症及手术修整率增加相关

Preoperative use of serotonergic antidepressants is associated with increased rates of complications and surgical revision in autologous breast reconstruction.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2025-08-29

本研究基于TriNetX美国协作网络数据库,纳入接受自体乳房再造的成年女性,比较术前3个月内使用5-羟色胺能抗抑郁药者(n=4434)与未使用者(n=13661),经倾向性评分匹配后每组3064例。结果显示用药组90天内脓毒症、血清肿、血肿和手术部位感染风险显著升高,1年和2年乳房畸形及修整率亦显著增加。

要点

  • 术前3个月使用5-羟色胺能抗抑郁药与自体乳房再造后90天内并发症风险升高相关。
  • 匹配后用药组脓毒症RR=1.94、血清肿RR=1.58、血肿RR=1.29、手术部位感染RR=1.54。
  • 用药组1年和2年乳房畸形及手术修整率亦显著升高(p<0.01)。

核心结论

  • 术前使用5-羟色胺能抗抑郁药与自体乳房再造术后短期和长期并发症增加相关。

研究设计与样本

  • 基于TriNetX美国协作网络的回顾性队列研究,纳入18岁以上接受自体乳房再造的女性。
  • 术前3个月内处方5-羟色胺能抗抑郁药组4434例,无使用者13661例,经倾向性评分匹配后每组3064例。
  • 主要结局为术后90天内并发症,次要结局为1年和2年乳房畸形与手术修整,采用风险比(RR)分析,p<0.05为显著。

主要发现

  • 匹配后用药组90天内脓毒症风险显著升高(RR=1.94,p=0.004)。
  • 匹配后用药组90天内血清肿风险显著升高(RR=1.58,p=0.004)。
  • 匹配后用药组90天内血肿风险显著升高(RR=1.29,p=0.037)。
  • 匹配后用药组90天内手术部位感染风险显著升高(RR=1.54,p<0.0001)。
  • 1年和2年乳房畸形及手术修整率在用药组亦显著升高(p<0.01)。

临床怎么用

  • 对拟行自体乳房再造的患者,术前应详细询问5-羟色胺能抗抑郁药使用情况并纳入风险评估。
  • 围手术期多学科协作管理(包括精神科)可能有助于优化用药与手术时机。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Depression and anxiety are common among women with breast cancer scheduled for autologous breast reconstruction, with selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors serving as the first-line treatments. Although effective for mood disorders, perioperative use of these medications has been linked to impaired hemostasis and wound healing in recovering patients. We evaluated the association between preoperative serotonergic antidepressants and complications following reconstructive breast surgery. METHODS: Female patients were identified from the US collaborative network within TriNetX, a globally federated database. Adults (18 years and older) who underwent autologous breast reconstruction were stratified into 2 groups: those prescribed serotonergic antidepressants within 3 months preoperatively (n = 4434), and those without any documented use (n = 13,661). Propensity score matching controlled for demographics and comorbidities. Primary outcomes were postoperative complications within 90 days. Secondary outcomes included deformity of reconstructed breast and surgical revision at 1 and 2 years. Risk ratios (RR) were used to measure associations, with statistical significance set at p < 0.05. RESULTS: After matching, 3064 patients remained in each group. Patients who used serotonergic antidepressants before autologous breast reconstruction had significantly higher risks of developing complications, including sepsis (RR = 1.94, p = 0.004), seroma (RR = 1.58, p = 0.004), hematoma (RR = 1.29, p = 0.037), and surgical site infection (RR = 1.54, p < 0.0001), within 90 days. At 1 and 2 years, the rates of breast deformity and revision were also significantly elevated (p < 0.01). CONCLUSION: Preoperative serotonergic antidepressant use is associated with increased short- and long-term complications following autologous breast surgery.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Dao MQ, Roth JM, Yu BZ, et al. Preoperative use of serotonergic antidepressants is associated with increased rates of complications and surgical revision in autologous breast reconstruction. J Plast Reconstr Aesthet Surg. 2025. PMID: 41043341. doi:10.1016/j.bjps.2025.08.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。